The reduction in viability observed in these CLL samples, as measured by FACS analysis of annexin V/PI staining, showed a strong positive correlation with the results from the XTT cell viability assay (mean ± SD: 69 ± 6% viability decrease at 1 μM HDM201). This evidence concerns the gene ANXA5 and B-cell chronic lymphocytic leukemia.